Blood-derived dendritic cell vaccinations induce immune responses that correlate with clinical outcome in patients with chemo-naive castration-resistant prostate cancer.

Harm WestdorpJeroen H A CreemersInge M van OortGerty SchreibeltMark A J GorrisNiven MehraMichiel SimonsAnna L de GoedeMichelle M van RossumAlexandra J CroockewitCarl G FigdorJ Alfred WitjesErik H J G AarntzenRoel D M MusMareke BrüningKatja PetryMartin GotthardtJelle O BarentszI Jolanda M de VriesWinald R Gerritsen

Published in: Journal for immunotherapy of cancer (2019)

ClinicalTrials.gov identifier NCT02692976, registered 26 February 2016, retrospectively registered.

Keyphrases

dendritic cells
immune response
regulatory t cells
photodynamic therapy
hiv infected
cancer therapy
combination therapy
drug delivery